Boceprevir for Untreated Chronic HCV Genotype 1 Infection

BACKGROUND: Peginterferon–ribavirin therapy is the current standard of care for chronic infection with hepatitis C virus (HCV). The rate of sustained virologic response has been below 50% in cases of HCV genotype 1 infection. Boceprevir, a potent oral HCV-protease inhibitor, has been evaluated as an...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Poordad, Fred, McCone, Jonathan, Bacon, Bruce R., Bruno, Savino, Manns, Michael P., Sulkowski, Mark S., Jacobson, Ira M., Reddy, K. Rajender, Goodman, Zachary D., Boparai, Navdeep, DiNubile, Mark J., Sniukiene, Vilma, Brass, Clifford A., Albrecht, Janice K., Bronowicki, Jean-Pierre
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3766849/
https://ncbi.nlm.nih.gov/pubmed/21449783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1010494
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items